# A Safety and Efficacy Study of Hospitalized Patients With Community-Acquired Pneumonia and Sepsis

> **NCT00042588** · PHASE2 · COMPLETED · sponsor: **ICOS Corporation**

## Conditions studied

- Pneumonia
- Sepsis

## Interventions

- **DRUG:** Recombinant Chimeric Monoclonal Antibody

## Key facts

- **NCT ID:** NCT00042588
- **Lead sponsor:** ICOS Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-05
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2005-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00042588

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00042588, "A Safety and Efficacy Study of Hospitalized Patients With Community-Acquired Pneumonia and Sepsis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00042588. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*